V. Jona

Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.

G. Droguett, M. Horwitz, N. Chowdhury, 1997, The Journal of clinical investigation.

Transient immunosuppression with FK506 permits long‐term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat

J. Roy-Chowdhury, Y. Ilan, A. Davidson, 1997, Hepatology.